Specific anti‐tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti‐tumor cytotoxicity by non‐immune lymphoid cells in vitro

Sera from tumor‐bearing mice induce specific cytotoxicity to tumor cells by non‐immune lymphoid cells (antiserum‐dependent cytotoxicity or ADC). When spleen cells from BALB/c mice bearing autochthonous or syngeneic sarcomas were cultured in vitro, culture supernatants were obtained which specifically sensitized sarcoma cells to injury in vitro by normal lymph‐node cells (LNC). Culture supernatants of spleen cells from mice whose transplanted sarcomas had been excised also induced ADC. The ADC activity resided in the mouse immunoglobulin fraction of the culture supernatants and its synthesis did not depend on the presence of theta‐positive cells. Following a brief in vivo exposure to culture supernatant with known ADC activity, LNC from non‐immune mice specifically destroyed tumor cells in an in vitro assay.

[1]  S. Pollack,et al.  Evidence for two factors in sera of tumor‐immunized mice which induce specific lymphoid cell‐dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM , 1975, International journal of cancer.

[2]  K. Hellström,et al.  Specific anti‐tumor responses by cultured immune spleen cells. I. In vitro culture method and initial characterization of factors which block immune cell‐mediated cytotoxicity in vitro , 1975, International journal of cancer.

[3]  E. Klein,et al.  Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s). , 1975, Journal of immunology.

[4]  P. Lange,et al.  Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract. , 1974, The New England journal of medicine.

[5]  J. Fahey,et al.  Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. , 1974, Journal of immunology.

[6]  K. Hellström,et al.  Serum effects on cell‐mediated destruction of rous sarcomas , 1973, International journal of cancer.

[7]  K. Hellström,et al.  Increase of lymphocyte‐mediated tumor‐cell destruction by certain patient sera , 1973, International journal of cancer.

[8]  S. Pollack,et al.  Effects of carrageenan and high serum dilution on synergistic cytotoxicity to tumor cells. , 1973, Journal of immunology.

[9]  R. Kiessling,et al.  CYTOTOXIC POTENTIAL OF MOUSE SPLEEN CELLS ON H-2 ANTIBODY-TREATED TARGET CELLS , 1973, The Journal of experimental medicine.

[10]  S. Pollack Specific “arming” of normal lymph‐node cells by sera from tumor‐bearing mice , 1973, International journal of cancer.

[11]  G. Heppner,et al.  Specific killing of tumor cells In vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens , 1972, International journal of cancer.

[12]  P. Biberfeld,et al.  Specifically cytotoxic lymphocytes produced by preincubation with antibody-complexed target cells. , 1972, Journal of immunology.

[13]  P. Cuatrecasas,et al.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. , 1970, The Journal of biological chemistry.

[14]  H. Sjögren,et al.  Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. , 1970, Cellular immunology.

[15]  W. Dandliker,et al.  Antibody purification at neutral pH utilizing immunospecific adsorbents. , 1968, Immunochemistry.